kaiko.ai’s Post

AI could change the way we think about healthcare forever, potentially saving many lives per year. What if we told you that the process is already underway? 💪 The latest advancements in artificial intelligence are making it possible to help design clinical trials to help defeat some of the hardest-to-treat diseases on earth, including cancer. Researchers and pharmaceutical companies are collaborating worldwide to harness the power of these technologies, showing that AI can help drive real-world impact. Take a moment to explore the potential impact of AI on cancer research and drug discovery and development, and how we’re helping our clients to reshape the future of cancer, in this series presented by Union for International Cancer Control (UICC), and produced for them by BBC StoryWorks Commercial Productions. You can see a snippet below, and check out the full video here. 👉 https://lnkd.in/eCf5hcXA #AIbyMcKinsey #ArtificialIntelligence #RewritingCancer

This is an excellent piece of work from Georgia, linking real world oncology data, chemotherapy regimes and outcomes for 15000 patients from #NDRS National cancer register in England. The inference of disease free survival is a significant step in large scale datasets. If you are in Basel, definitely one to check out and really exemplifing the novel thought leadership in oncology at Genomics England Matthew Brown Richard Scott Emma McCargow #cancer #realworlddata #bigdata #ndrs #ncras

Interested in learning more about GenomOncology? Check out our new presentation TODAY at 4 pm on the AI for Oncology track at #BioIT! Join Ian Maurer, our CTO, as he breaks down how to make multi-omic data actionable in a clinical setting. Learn more about how GenomOncology addresses the challenges and complexity involved with interpreting biomarkers, identifying patient cohorts, and finding potential treatment options. We look forward to seeing you there! #precisionmedicine #precisiononcology #clinicaltrials

👀🎬 A look back on the first edition of #THRPTX. Few days ago, we hosted the inaugural Therapeutics Innovation Summit (THRPTX) at our R&D Institute at Paris-Saclay. This groundbreaking event brought together world-renowned scientists, researchers, and industry leaders to explore the frontiers of medical innovation, with a focus on oncology. 🔎 From AI-driven drug discovery to cutting-edge immunotherapies, the discussions illuminated pathways to transform patient care. Prof. William G. Kaelin, 2019 Nobel Laureate in Medicine, set the tone with his inspiring keynote on cellular adaptation to oxygen availability. 👉 The summit exemplified our commitment to open innovation and collaborative research. By fostering dialogue between diverse stakeholders, we aim to accelerate therapeutic progress and address unmet medical needs. 🙏 We're immensely grateful to all participants for their invaluable contributions. The insights gained will fuel our ongoing efforts to develop innovative solutions for patients facing cancer. Read more 👉 https://swll.to/xDshrVA #WeAreServier #MovedByYou #innovation #health

First Day of BioTechX is here!    We are happy that our time at the BioTechX in Basel has been a great success so far! 🎉 Today, we had an engaging poster presentation and an insightful talk that sparked discussions and interest.   If you're around, be sure to stop by our booth #828 to chat with our team and to learn more about our multi-omic multivariate approach for Target ID in Oncology.   Looking forward to meeting more of you tomorrow 👋🏼  #biotechx #multiomics #data #targetidentification #cancerresearch

Unlock vital insights into your experimental treatments with advanced molecular and cellular assays! 🔬 With expert analysis and integrative consultations, we ensure you fully understand the #efficacy and safety of your therapies. Together with Accelevir Diagnostics we’ll accelerate your journey from discovery to clinical trials. Learn more: https://ow.ly/fm3i50TTUR9 #assays #cellandgene #research #data #oncology #infectiousdisease

Discover how leveraging real world data can illuminate the path to successful biomarker discovery and targeted drug development. Register at https://buff.ly/4f1b76a Featuring: - Keith Flaherty, MD, Director of Clinical Research at the Massachusetts General Hospital Cancer Centre and Professor of Medicine at Harvard Medical School - Siraj A., MD, Global Vice President, Translation Medicine, Lunit - Saurabh Sewak, PhD, VP, Corporate and Business Development, Foghorn Therapeutics - Eleonora Iob, PhD, Research Manager, PHARMO Institute, part of Lumanity - Dennis Chang, PhD, SVP, Strategy Consulting, Lumanity Can't make it? Register to get the recording. #PrecisionOncology #RealWorldData #DrugDevelopment #Oncology #RWE #RealWorldEvidence

Discover how leveraging real world data can illuminate the path to successful biomarker discovery and targeted drug development. Register at https://buff.ly/3UPwcbR Featuring: - Keith Flaherty, MD, Director of Clinical Research at the Massachusetts General Hospital Cancer Centre and Professor of Medicine at Harvard Medical School - Siraj A., MD, Global Vice President, Translation Medicine, Lunit - Saurabh Sewak, PhD, VP, Corporate and Business Development, Foghorn Therapeutics - Eleonora Iob, PhD, Research Manager, PHARMO Institute, part of Lumanity - Dennis Chang, PhD, SVP, Strategy Consulting, Lumanity Can't make it? Register to get the recording. #PrecisionOncology #RealWorldData #DrugDevelopment #Oncology #RWE #RealWorldEvidence

Our CEO, Greg Hamilton, connected with BiotechTV’s Brian Orelli, PhD following the positive study published yesterday in the Journal of Clinical Oncology about our #AI-powered biomarker test, DeepHRD. Watch the video below to learn how we are working to revolutionize #cancer treatment decisions by ensuring that more patients receive the correct first-line treatments promptly, reducing delays, cost and increasing access to #precisiononcology medicines. Watch the full video here: https://lnkd.in/g-6Rp3bT

🔬 Exciting News in Cancer Research! 🔬    I'm thrilled to announce a groundbreaking collaboration between SCRI and AstraZeneca! Together, we will focus on leveraging technology enhancements and an innovative clinical trial operational model to advance cancer research.    This collaboration marks a significant milestone in our collective efforts to combat cancer. By combining expertise and resources, we aim to accelerate the discovery of new treatments and improve patient outcomes.    Stay tuned for updates on the incredible breakthroughs and advancements that will emerge from this collaboration. Together, we're shaping the future of oncology research!    #CancerResearch #Collaboration #Innovation #Oncology #Advancements #PatientOutcomes #ClinicalTrials